{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Werewolf Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"HOWL"},"Address":{"label":"Address","value":"1030 MASSACHUSETTS AVENUE,SUITE 210, CAMBRIDGE, Massachusetts, 02138, United States"},"Phone":{"label":"Phone","value":"+1 617 952-0555"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer."},"CompanyUrl":{"label":"Company Url","value":"https://www.werewolftx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Chulani Karunatilake","title":"Chief Technology Officer"},{"name":"Daniel J. Hicklin","title":"President, Chief Executive Officer & Director"},{"name":"Randi Isaacs","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}